Trident Texofab Schedules Board Meeting to Approve Q2 Results
Trident Texofab Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Trident Texofab Schedules Board Meeting to Approve Q2 Results Trident Texofab Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited standalone financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for the company's equity shares, which closed on 1st Oct'26, will reopen 48 hours after the financial results are made public.
Original exchange filing (PDF)
More announcements from Trident Texofab Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust 路 18 Nov 2026
- The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and half year ended on September 30, 2026 along with Limited Review .... 路 06 Nov 2026
- Outcome of Board Meeting held on 05.11.2026 路 06 Nov 2026
- KFin Technologies Limited (RTA) - Shifting of Corporate Office 路 03 Nov 2026
- Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed details of voting results inclusive of remote e-voting .... 路 30 Oct 2026
- Further to our letter dated 03rd October, 2026 and pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith summary .... 路 28 Oct 2026
- We would like to inform you that the Extra-Ordinary General Meeting is scheduled to be held on Wednesday, October 28, 2026, at 04.00 p.m. (IST) through Video Conferencing ("VC") or Other .... 路 06 Oct 2026
- Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you about that, based on the recommendation of the Audit Committee, .... 路 03 Oct 2026
